| 摘要 |
<p>The present invention relates to a new medical use of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz [2,3:6,7] oxepino[4,5-c]pyrrole, or a pharmaceutically acceptable acid addition salt or solvate thereof and to a new method of treatment for depression.</p> |
